Dr. Berger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 1st Ave
# 9R
New York, NY 10016Phone+1 212-263-4004
Summary
- Dr. Jeffrey Berger is a cardiologist in New York, NY and is affiliated with NYU Langone Hospitals. He received his medical degree from Tel Aviv University Sackler, and has been in practice 12 years. He specializes in cardiovascular prevention and vascular medicine and is a transitional scientist investigating platelets and thrombosis.
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 2005 - 2008
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2001 - 2005
- Albert Einstein College of MedicineM.S., Clinical Research, 2005
- Tel Aviv University SacklerClass of 2001
- Yeshiva UniversityB.A., Psychology, Cum Laude, 1995
Certifications & Licensure
- NY State Medical License 2003 - 2026
- PA State Medical License 2008 - 2010
Awards, Honors, & Recognition
- Leon H. Charney Lecture Award 2014
- Irma T. Hirschl/Monique Weill-Caulier Trusts Research Award 2013
- Saul J. Farber Scholar 2012
- Join now to see all
Clinical Trials
- Prevention Trial to Achieve Cardiovascular Targets Start of enrollment: 2012 Jun 01
- Risk Factor Control Before Orthopedic Surgery Start of enrollment: 2014 Feb 01
- Platelet Activity in Vascular Surgery for Thrombosis and Bleeding Start of enrollment: 2013 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsEffect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open...Mikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, Jeffrey S Berger, Harmony R Reynolds
The Lancet. Diabetes & Endocrinology. 2024-10-01 - Cardiovascular adverse event reporting in psoriasis and psoriatic arthritis biological therapy clinical trials.Sreejan Saha, Molly Ottensoser, Brittany N Weber, Jeffrey S Berger, Michael S Garshick
International Journal of Women's Dermatology. 2024-10-01 - 5 citationsAtherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.Nick S Nurmohamed, James K Min, Rebecca Anthopolos, Harmony R Reynolds, James P Earls
European Heart Journal. 2024-09-29
Journal Articles
- To DOAC or Not to DOAC for Left Ventricular Thrombi—What Is the Dose?Arun Manmadhan, Jeffrey S Berger, JAMA Cardiology
- Perioperative Cardiovascular Risk Assessment and Management for Noncardiac SurgeryNathaniel R Smilowitz, Jeffrey S Berger, JAMA
- Thrombosis in Hospitalized Patients with COVID-19 in a New York City Health SystemJudith Hochman, Jeffrey S Berger, JAMA
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- [Board 372] Incidence of Cardiovascular Events Among Real-World Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease Receiving AspirinJeffrey Berger, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/18/2019
- AIDS Neuropathy: Presence of Autoantibodies to Peripheral Nerve Antigens.Briani C, Dalakas, Zakir R, Revesz K, Berger J, Sivac M, Brannagan T, Latov N, Neurology, 1/1/1996
Lectures
- Late-Breaking Clinical Trials: Interventional2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Case #3: A 30 Year Old Woman With Factor V Leiden and DVT on OCP Contemplating Pregnancy2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
- Original Investigation Combining Oral Anticoagulants with Platelet Inhibitors in Patients with Atrial Fibrillation and Coronary DiseaseScientific Sessions 2005, Dallas, Texas, USA
- Join now to see all
Authored Content
- Perioperative Cardiovascular Risk Assessment and Management for Noncardiac SurgeryJuly 2020
- Thrombosis in Hospitalized Patients with COVID-19 in a New York City Health SystemJuly 2020
- Risk of Ischemic Stroke in Patients Newly Diagnosed with Heart Failure: Focus on Patients Without Atrial FibrillationMarch 2018
- Risk of Ischemic Stroke in Patients Newly Diagnosed with Heart Failure: Focus on Patients Without Atrial FibrillationMarch 2018
- Platelet-Derived MRP-14 Induces Monocyte Activation in Patients with Symptomatic Peripheral Artery DiseaseJanuary 2018
- Platelet-Derived MRP-14 Induces Monocyte Activation in Patients with Symptomatic Peripheral Artery DiseaseJanuary 2018
- Join now to see all
Press Mentions
- Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart DiseaseDecember 2nd, 2024
- Blood Platelet Test Could Save Millions of Americans from Heart Attacks and StrokesSeptember 16th, 2024
- Researchers Develop Tool That Reliably Predicts Blood Platelet Hyperreactivity and Risk of StrokeAugust 27th, 2024
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: